Patent ID: 7514401

Claim:
A method for the administration of a therapeutic amount of a growth factor protein formulation in the treatment of a patient displaying the symptoms of acute coronary artery disease comprising the steps of: a) administering at least one dose of an effective amount of a first therapeutic growth factor protein formulation, by oral inhalation therapy, comprising: 1. a growth factor protein selected from the group consisting of FGF-1 and FGF-2, and mixtures thereof; and 2. a growth factor protein selected from the group consisting of VEGF, VEGF-A, VEGF-B, and PIGF, and mixtures thereof; b) monitoring one or more clinical indicators of acute coronary artery disease; c) determining, based on monitoring the one or more clinical indicators of acute coronary artery disease, whether an additional dose of a therapeutic growth factor protein formulation is indicated; d) depending on the results of step c), administering one or more additional doses of a second growth factor protein formulation, by either the same or an alternative method of delivery utilized for administration of the previous dose, comprising: 1. a growth factor protein being selected from the group consisting of FGF1 and FGF-2, and mixtures thereof; and 2. a growth factor protein selected from the group consisting of VEGF, VEGF-A, VEGF-B, and PIGF, and mixtures thereof; and repeating steps b) through d) until there is a clinical indication of amelioration of the symptoms of acute coronary artery disease in the patient, or until there is a contraindication to continued treatment.